Delivering News On Public Companies Within The Cannabis Sector

Another way to invest in cannabis that may help diversify and spread risk is to invest in a Holding Company. The purpose of any legal holding company is not to promote and sell a single product or service, but rather to amass capital through the ownership of subsidiary companies that sell a product or service.  There are some well-known Holding companies specializing in the conglomeration of cannabis companies who are gaining strong attention from investors. Holdings companies such as Potnetwork Holdings, Inc.(OTC:POTN) which owns Diamond CBD, Inc. Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils.  www.DiamondCBD.com. Dakshidin Corporation (OTCPK:DKSC) is another who just announced that it has completed the acquisition of Whitechapel Holdings, Inc. (Whitechapel), a Delaware Corporation and its wholly owned subsidiaries. Also notable is North American Cannabis Holdings, Inc. (OTCPK:USMJ),  which appears to be buying into whatever is hot and is acting more like a marijuana mutual fund than a Holding company. Given the volatility of the markets and to a greater extent the micro-cap cannabis market, there are strong possibilities for gains yet equally strong potential for losses with USMJ.  Most experts agree that this level of risk should only be invested in with money that the investor is willing to have fully at risk. For Comments, Questions or to suggest a news feature please contact: Editor@CannabisStocksNews.com

With Cannabis stocks soaring despite marijuana still being federally illegal, some investors are flocking to companies that are positioned to profit whom also remain outside of any illegal activity. These companies are poised to benefit from explosive industry developments, yet are uniquely positioned outside of being classified as marijuana companies. With several major beverage companies investing millions in developing products for the now legal CBD market, expected to generate over $22 billion in sales by 2022,  only one has rolled out a product to the US consumers. Mere weeks after President Trump signed the FARM Bill making Hemp and CBD legal; one of the best known coffee companies in America, Baristas Coffee (OTCPK:BCCI) has just released CBD infused coffee under its Baristas “EnrichaRoast CBD” infused coffee line. Enricharoast CBD infused ground coffee allows the customer to enjoy the combination of CBD, Caffeine and other therapeutic properties while enjoying a first-rate cup of coffee. This introduces an entirely new line of infused beverages into the American Market, and is now available for purchase at www.baristas.tv with nationwide shipping available to consumers which is expected to have a positive impact on revenues.  Adding to the growth and development for Baristas is the acquisition of advertising placed at the upcoming Superbowl, and strong celebrity endorsements from international superstar Front Montgomery and recording artist Megs McClean in previous NFL Monday and Thursday Night Football games. While the number of products within the cannabis space continues to grow exponentially the companies producing these products still face a serious problem informing the mainstream consumer that they exist. Mainstream media is still shying away from or outright banning any cannabis related products or services from being promoted on many mainstream media outlets that distribute their message on a national basis.

One cannabis company has significantly solved this issue evolving into the premiere Canna Broadcasting Media Company. Canna Consumer Goods, Inc. / DBA Canna Broadcast Media (OTCPK:CBMJ) www.cannabroadcastmedia.com CBMJ is able to provide access to mainstream media to cannabis companies through developed relationships as a content provider to traditional broadcast television networks and to more than 700 terrestrial (over the air) radio stations making it the immediate choice for companies wishing to advertise their cannabis and CBD products. Canna Broadcast Media specializes in getting mainstream media cleared promoting the cannabis sector including network TV, radio, and digital ads targeting those who wish to take advantage of the incredible investment opportunities that exist in the cannabis sector.  Canna Broadcast Media also acquired "LoudMouth News" www.loudmouthnews.com which became the first and longest running syndicated “Over the Air” terrestrial radio news program that focused on the news relating to the marijuana industry. No other company has been successful in getting cannabis companies exposure and ad placements on mainstream media and unless marijuana becomes legal on a federal level it is unlikely that they will have much if any competition. Another area within the “legal” cannabis sector getting a significant amount of attention recently comes from the fact that a main issue hindering progress of federal legalization is that there is limited information from research on Cannabis as historically very few were allowed to conduct testing on the illegal substance. This is still true in the US and other countries where cannabis is not legal leading to opportunities in regions where research is permitted. Cannabics Pharmaceuticals (OTCQB:CNBX)  stands out as one company that has solved this issue. Cannabics is operated out of Israel where it is fully licensed by the Ministry of Health. The research at the facility is devoted to the discovery of cannabinoid compounds targeted to specific cancers. This cancer focused research has created a strong identity for the company. Mr. Barad the companies CEO is deeply enthusiastic about the current path of the company and its various prototype products/services soon to be available to the public. Cannabics is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. For the latest updates on Cannabics Pharmaceuticals follow the company on Twitter @cannabics1, Facebook @CannabicsPharmaceuticals and LinkedIn.